SPIA
BIOR

Steward Partners Investment Advisory’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Steward Partners Investment Advisory’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed -$16 – 4164
2024
Q3 		$16 Hold
3
– – ﹤0.01% 3719
2024
Q2 		$21 Hold
3
– – ﹤0.01% 3592
2024
Q1 		$35 Hold
3
– – ﹤0.01% 3539
2023
Q4 		$43 Hold
3
– – ﹤0.01% 3466
2023
Q3 		$69 Hold
3
– – ﹤0.01% 3327
2023
Q2 		$123 Hold
3
– – ﹤0.01% 3261
2023
Q1 		$89 Hold
3
– – ﹤0.01% 3259
2022
Q4 		$105 Hold
3
– – ﹤0.01% 3292
2022
Q3 		$0 Buy
+3
New +$540 ﹤0.01% 3476
2022
Q1 		– Sell
-120
Closed -$63K – 3434
2021
Q4 		$63K Buy
120
+60
+100% +$43.1K ﹤0.01% 1797
2021
Q3 		$23K Buy
+60
New +$25.7K ﹤0.01% 2274

Steward Partners Investment Advisory's BIOR Position: Q4 2024 in Review

Steward Partners Investment Advisory sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2024, closing a stake of 3 shares — an estimated $16 sold.

Steward Partners Investment Advisory first reported a position in BIOR in Q3 2021 and held it in 11 quarters. The position peaked at $63K in Q4 2021. 0 funds tracked by Wall St. Rank hold BIOR as of Q4 2024.

  • Steward Partners Investment Advisory reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 3 Biora Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $16.
  • Steward Partners Investment Advisory first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Steward Partners Investment Advisory's Biora Therapeutics, Inc. Common Stock position peaked at $63K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2024, filed 6 Feb 2025.